| |
| |
|
| Insider
Information: |
Dunlop A. Sinclair |
| Relationship: |
Director |
| City: |
Crestwood |
| State: |
KY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
133,518 |
|
|
Indirect Shares
|
205,853 |
|
|
| Direct
Value |
$6,517,014 |
|
|
|
Indirect Value
|
$10,047,685 |
|
|
| Total
Shares |
339,371 |
|
|
| Total
Value |
$16,564,699 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
14
|
|
Stock
price went up :
|
0
|
8
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.3
|
| Percentage
Gain/Loss : |
0.0%
|
 134.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
Director |
2024-04-12 |
133,518 |
2024-04-12 |
205,853 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2024-04-12 |
4 |
OE |
$13.19 |
$19,785 |
D/D |
1,500 |
133,518 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
|
– • – |
2024-03-19 |
4 |
S |
$57.18 |
$1,068,161 |
I/I |
(18,681) |
173,998 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,341 |
132,018 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-12-14 |
4 |
OE |
$13.19 |
$82,754 |
D/D |
6,274 |
128,677 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
|
– • – |
2023-12-01 |
4 |
S |
$61.14 |
$1,467,240 |
I/I |
(24,000) |
192,679 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-11-17 |
4 |
S |
$49.99 |
$444,620 |
D/D |
(8,894) |
122,403 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2023-10-17 |
4 |
S |
$49.00 |
$1,176,000 |
I/I |
(24,000) |
216,679 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-04-03 |
4 |
AS |
$74.05 |
$37,025 |
D/D |
(500) |
131,297 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-03-01 |
4 |
AS |
$65.33 |
$32,665 |
D/D |
(500) |
131,797 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-02-01 |
4 |
AS |
$52.61 |
$26,305 |
D/D |
(500) |
132,297 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-01-03 |
4 |
AS |
$50.70 |
$25,350 |
D/D |
(500) |
132,797 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2023-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,867 |
133,297 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2022-12-01 |
4 |
AS |
$49.93 |
$24,965 |
D/D |
(500) |
129,430 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2022-11-01 |
4 |
AS |
$60.83 |
$30,415 |
D/D |
(500) |
129,930 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-09-08 |
4 |
S |
$65.00 |
$975,000 |
I/I |
(15,000) |
240,679 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-08-25 |
4 |
OE |
$13.19 |
$56,796 |
D/D |
4,306 |
130,430 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-08-16 |
4 |
OE |
$14.00 |
$355,516 |
D/D |
25,394 |
126,124 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-08-11 |
4 |
S |
$65.63 |
$1,968,900 |
I/I |
(30,000) |
255,679 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-07-21 |
4 |
OE |
$14.00 |
$134,484 |
D/D |
9,606 |
100,730 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2022-06-27 |
4 |
S |
$46.79 |
$62,743 |
I/I |
(1,341) |
1,341 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2022-06-23 |
4 |
S |
$45.00 |
$675,000 |
I/I |
(15,000) |
285,679 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-04-22 |
4 |
OE |
$14.00 |
$280,000 |
D/D |
20,000 |
91,124 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,230 |
71,124 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2021-09-10 |
4 |
OE |
$14.00 |
$96,516 |
D/D |
6,894 |
66,894 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2021-06-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(31,855) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
